Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized phase I/II neoadjuvant trial of paclitaxel versus BIBF 1120 priming followed by BIBF 1120 plus paclitaxel in HER2-negative breast cancer
2011-001649-34Phase 2Completed
- Sponsor
- Spanish National Cancer Research Centre
- Start
- Jul 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in breast cancer comparing Paclitaxel neoadjuvant control arm with BIBF 1120 lead-in followed by BIBF 1120 plus paclitaxel (2 arms). Started Jul 2011; status: completed.
02
Drugs
nintedanibpaclitaxel
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2011-001649-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-001649-34.